Experienced in Transient Ischemic Attack (TIA)

Laurent Macle

5000 Rue Bélanger, 
Montreal, QC, CA 
Experienced in Transient Ischemic Attack (TIA)
5000 Rue Bélanger, 
Montreal, QC, CA 
OverviewLocationsClinical Research

Overview

Laurent Macle practices in Montreal, Canada. Mr. Macle is rated as an Experienced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Atrial Fibrillation, Arrhythmias, Heart Block, Ventricular Fibrillation, and Cardiac Ablation.

His clinical research consists of co-authoring 192 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 1 clinical trial in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

5000 Rue Bélanger, Montreal, QC H1T1C8, Canada
Other Locations
Canada
Toronto, ON, Canada
Sherbrooke, Rouge Valley Centenary Hospital, Calgary, AB, St. Mary's Hospital, Hamilton, ON, St. Michael's Hospital, Ottawa, ON, Canada
Sherbrooke, Rouge Valley Centenary Hospital, Calgary, AB, St. Mary's General Hospital, Victoria, Hamilton, ON, St. Michael's Hospital, Prince Albert, SK, Canada
Vancouver, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF (BRAIN-AF)
Enrollment Status: Terminated
Publish Date: June 15, 2025
Intervention Type: Other, Drug
Study Drug: Rivaroxaban
Study Phase: Phase 3
RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
Enrollment Status: Completed
Publish Date: April 10, 2025
Intervention Type: Drug
Study Drugs: Vernakalant, Procainamide
Study Phase: Phase 4
Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF (STSF) Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT)
Prospective Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF (STSF) Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT)
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Randomized, Controlled Comparison of Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter (RAFF)
A Randomized, Controlled Comparison of Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter (RAFF)
Enrollment Status: Completed
Publish Date: July 22, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

192 Total Publications

Relationship Between Time-to-First Atrial Tachyarrhythmia Recurrence and Atrial Fibrillation Burden: Implications for Trial Design.
Relationship Between Time-to-First Atrial Tachyarrhythmia Recurrence and Atrial Fibrillation Burden: Implications for Trial Design.
Journal: Circulation. Arrhythmia and electrophysiology
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Macle's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile